Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IMMUNIC, INC.IMUX · Entity 6306 | Director | July 05, 2026 | July 07, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IMMUNIC, INC.
Report date July 05, 2026 · Filed July 07, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $14.80 · Expires 2036-07-05 | Direct | 25,370 |
Reported balance
After 2026-07-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-05 · Grant · Acquired 25,370 · Balance 25,370 F1: The option vests in monthly increments over a period of one year from the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests in monthly increments over a period of one year from the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2026 Filed Jul 7, 2026 20:06 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 25,370 | $0.00 Strike: $14.80 | $0.00 |
DisclosureSEC source: 0001193805-26-000931 · e665634_4-rudick.xml · derivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,370 Underlying: Common Stock · 25,370 shares Expires 2036-07-05 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 29, 2026 Filed Jun 29, 2026 20:33 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 25,370 | $0.00 Strike: $10.90 | $0.00 |
DisclosureSEC source: 0001193805-26-000890 · e665610_4-rudick.xml · derivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,370 Underlying: Common Stock · 25,370 shares Expires 2036-03-27 F1 · shares: Represents options to purchase shares of common stock conditionally approved by the Board of Directors on March 27, 2026, subject to approval of an amendment to the Company's 2019 Omnibus Equity Incentive Plan, as amended, by the Company's stockholders, which approval was obtained at the Company's 2026 Annual Meeting of Stockholders held on June 29, 2026. F2 · derivative.exercise_date: The option is fully vested as of March 27, 2026. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:08 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 150,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001193805-25-000841 · e664610_4-rudick.xml · derivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 20:06 UTC | IMMUNIC, INC. IMUX · Entity 6306 | PurchaseCommon Stock | 143,075 | $0.70 | $100,023.73 |
DisclosureSEC source: 0001193805-25-000786 · e664585_4-rudick.xml · nonDerivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,375 F1 · shares: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6955 to $0.6993. The Reporting Person (RP) undertakes to provide to the Issuer, any securityholder of the Issuer, or the SEC staff, upon request, information regarding the number of shares purchased at each price. Read SEC document |
| November 12, 2024 Filed Nov 13, 2024 19:13 UTC | IMMUNIC, INC. IMUX · Entity 6306 | PurchaseCommon Stock | 87,300 | $1.15 | $100,368.81 |
DisclosureSEC source: 0001193805-24-001335 · e664024_4-rudick.xml · nonDerivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,300 Read SEC document |
| June 11, 2024 Filed Jun 12, 2024 20:07 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $1.27 | $0.00 |
DisclosureSEC source: 0001193805-24-000786 · e663705_4-rudick.xml · derivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-06-11 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| June 28, 2023 Filed Jun 29, 2023 20:39 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 16,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001193805-23-000919 · e618744_4-rudick.xml · derivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2033-06-28 F1 · derivative.exercise_date: The option vests in monthly increments over a period of one year from the grant date. Read SEC document |
| April 26, 2023 Filed Apr 27, 2023 12:30 UTC | IMMUNIC, INC. IMUX · Entity 6306 | GrantStock Option · Derivative | 32,000 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001193805-23-000613 · e618551_4-rudick.xml · derivative · entry 1 Rudick Richard Alan · CIK 0001975263 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 Underlying: Common Stock · 32,000 shares Expires 2033-04-26 F1 · derivative.exercise_date: The options vest in monthly increments over a period of three years from the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.